Works matching IS 17501326 AND DT 2017 AND VI 12 AND IP 1

Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome.

Published in:

Molecular Neurodegeneration, 2017, v. 12, n. 1, p. 1, doi. 10.1186/s13024-017-0206-8

By:

• Harutsugu Tatebe;
• Takashi Kasai;
• Takuma Ohmichi;
• Yusuke Kishi;
• Tomoshi Kakeya;
• Masaaki Waragai;
• Masaki Kondo;
• Allsop, David;
• Takahiko Tokuda

Publication type:

Article